close
close
migores1

Viking Therapeutics stock rose on positive data from the treatment study for the rare metabolic disorder X-ALD

Photo of Vaseline VaselineOctober 9, 2024
0 Less than a minute
Viking Therapeutics stock rose on positive data from the treatment study for the rare metabolic disorder X-ALD

Viking Therapeutics stock rose on positive data from the treatment study for the rare metabolic disorder X-ALD

Viking, which is also developing a diet pill, has a buy rating from all 13 analysts providing coverage.

Photo of Vaseline VaselineOctober 9, 2024
0 Less than a minute
Photo of Vaseline

Vaseline

Related Articles

General Motors (NYSE:GM) shares position was raised by Addison Advisors LLC

General Motors (NYSE:GM) shares position was raised by Addison Advisors LLC

September 7, 2024
RiverStone confirms it took .2bn in .6bn QBE deal

RiverStone confirms it took $1.2bn in $1.6bn QBE deal

August 9, 2024
Crypto Analyst Doubts Bitcoin’s Dominance “Returns” to 70% Again

Crypto Analyst Doubts Bitcoin’s Dominance “Returns” to 70% Again

August 18, 2024
The 50 bps cut was the right move

The 50 bps cut was the right move

September 20, 2024
Back to top button